FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3084313144> ?p ?o ?g. }

• W3084313144 endingPage "1707" @default.
• W3084313144 startingPage "1697" @default.
• W3084313144 abstract "Crohn's disease is a severe, incurable inflammatory bowel disease. Orally administered emu oil has demonstrated anti-inflammatory properties in previous models of gastrointestinal disease. We aimed to determine whether orally administered emu oil could attenuate disease in a mouse model of Crohn's-like colitis. Female ARC(s) mice (CD-1 equivalent, n = 10/group) were intra-rectally administered water (120 μL) or trinitrobenzene sulfonic acid (TNBS; 3 mg in 50% ethanol; 120 μL bolus) on day 0. Mice were orally administered water (80 μL) or emu oil (80 μL or 160 μL) daily for five days and euthanized on day six. Bodyweight and disease activity were recorded daily. Colonoscopy, burrowing activity, facial grimace, histological parameters (damage severity, small intestinal villus height/crypt depth and colonic crypt depth), myeloperoxidase activity and intestinal permeability were assessed. P < 0.05 was considered statistically significant. TNBS decreased bodyweight (days 1, 2, 4; P < 0.05) and increased disease activity (days 1-6; P < 0.01), compared to normal controls. Emu oil (80 μL) attenuated disease activity on days 5-6 (P < 0.05), although bodyweight loss was not significantly impacted (P > 0.05). Facial grimace and colonoscopy scores were significantly increased in TNBS-control mice; effects attenuated by both volumes of emu oil (P < 0.001). TNBS increased histological damage severity compared to normal controls (P < 0.05); an effect attenuated by 80 μL emu oil (proximal and distal colon; P < 0.05) and 160 μL emu oil (distal colon; P < 0.01). In the ileum, villus height and crypt depth were unaffected by TNBS or emu oil treatment compared to normal (P > 0.05). TNBS-induced distal colonic crypt lengthening was unaffected following emu oil administration (P > 0.05). Remaining parameters, including burrowing, myeloperoxidase activity and intestinal permeability, were unchanged across all treatment groups (P > 0.05). In normal mice, emu oil treatment did not significantly impact any parameter compared to normal controls. In conclusion, emu oil reduced overall disease severity and facial grimace scores in TNBS mice. These results suggest therapeutic potential for orally administered emu oil in the management of Crohn's disease." @default.
• W3084313144 created "2020-09-14" @default.
• W3084313144 creator A5000542010 @default.
• W3084313144 creator A5014696178 @default.
• W3084313144 creator A5022554913 @default.
• W3084313144 creator A5023059624 @default.
• W3084313144 creator A5042590576 @default.
• W3084313144 creator A5053408204 @default.
• W3084313144 creator A5082660379 @default.
• W3084313144 date "2020-09-09" @default.
• W3084313144 modified "2023-09-27" @default.
• W3084313144 title "Orally administered emu oil attenuates disease in a mouse model of Crohn’s-like colitis" @default.
• W3084313144 cites W1977111258 @default.
• W3084313144 cites W1980018183 @default.
• W3084313144 cites W1995711439 @default.
• W3084313144 cites W2003563101 @default.
• W3084313144 cites W2007378946 @default.
• W3084313144 cites W2016891401 @default.
• W3084313144 cites W2020098484 @default.
• W3084313144 cites W2024824255 @default.
• W3084313144 cites W2040391599 @default.
• W3084313144 cites W2046231469 @default.
• W3084313144 cites W2059848381 @default.
• W3084313144 cites W2068605509 @default.
• W3084313144 cites W2068698792 @default.
• W3084313144 cites W2073243597 @default.
• W3084313144 cites W2081370753 @default.
• W3084313144 cites W2082035385 @default.
• W3084313144 cites W2089718825 @default.
• W3084313144 cites W2094761188 @default.
• W3084313144 cites W2098733700 @default.
• W3084313144 cites W2115112818 @default.
• W3084313144 cites W2120214938 @default.
• W3084313144 cites W2125877781 @default.
• W3084313144 cites W2128818259 @default.
• W3084313144 cites W2130323999 @default.
• W3084313144 cites W2132202373 @default.
• W3084313144 cites W2146306841 @default.
• W3084313144 cites W2151088711 @default.
• W3084313144 cites W2167149704 @default.
• W3084313144 cites W2320980202 @default.
• W3084313144 cites W2335851787 @default.
• W3084313144 cites W2336349459 @default.
• W3084313144 cites W2341695064 @default.
• W3084313144 cites W2516300046 @default.
• W3084313144 cites W2607477783 @default.
• W3084313144 cites W2775174947 @default.
• W3084313144 cites W2801354090 @default.
• W3084313144 cites W2875613759 @default.
• W3084313144 cites W2944917253 @default.
• W3084313144 cites W4249181320 @default.
• W3084313144 cites W4250221969 @default.
• W3084313144 doi "https://doi.org/10.1177/1535370220951105" @default.
• W3084313144 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7802385" @default.
• W3084313144 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32903038" @default.
• W3084313144 hasPublicationYear "2020" @default.
• W3084313144 type Work @default.
• W3084313144 sameAs 3084313144 @default.
• W3084313144 citedByCount "4" @default.
• W3084313144 countsByYear W30843131442021 @default.
• W3084313144 countsByYear W30843131442022 @default.
• W3084313144 countsByYear W30843131442023 @default.
• W3084313144 crossrefType "journal-article" @default.
• W3084313144 hasAuthorship W3084313144A5000542010 @default.
• W3084313144 hasAuthorship W3084313144A5014696178 @default.
• W3084313144 hasAuthorship W3084313144A5022554913 @default.
• W3084313144 hasAuthorship W3084313144A5023059624 @default.
• W3084313144 hasAuthorship W3084313144A5042590576 @default.
• W3084313144 hasAuthorship W3084313144A5053408204 @default.
• W3084313144 hasAuthorship W3084313144A5082660379 @default.
• W3084313144 hasBestOaLocation W30843131442 @default.
• W3084313144 hasConcept C121608353 @default.
• W3084313144 hasConcept C126322002 @default.
• W3084313144 hasConcept C2775862500 @default.
• W3084313144 hasConcept C2777226302 @default.
• W3084313144 hasConcept C2778260677 @default.
• W3084313144 hasConcept C2778435480 @default.
• W3084313144 hasConcept C2779134260 @default.
• W3084313144 hasConcept C2779280984 @default.
• W3084313144 hasConcept C2780941987 @default.
• W3084313144 hasConcept C526805850 @default.
• W3084313144 hasConcept C66090201 @default.
• W3084313144 hasConcept C71924100 @default.
• W3084313144 hasConcept C90924648 @default.
• W3084313144 hasConceptScore W3084313144C121608353 @default.
• W3084313144 hasConceptScore W3084313144C126322002 @default.
• W3084313144 hasConceptScore W3084313144C2775862500 @default.
• W3084313144 hasConceptScore W3084313144C2777226302 @default.
• W3084313144 hasConceptScore W3084313144C2778260677 @default.
• W3084313144 hasConceptScore W3084313144C2778435480 @default.
• W3084313144 hasConceptScore W3084313144C2779134260 @default.
• W3084313144 hasConceptScore W3084313144C2779280984 @default.
• W3084313144 hasConceptScore W3084313144C2780941987 @default.
• W3084313144 hasConceptScore W3084313144C526805850 @default.
• W3084313144 hasConceptScore W3084313144C66090201 @default.
• W3084313144 hasConceptScore W3084313144C71924100 @default.
• W3084313144 hasConceptScore W3084313144C90924648 @default.
• W3084313144 hasIssue "18" @default.

• next